Cargando…

Identification of ebselen and its analogues as potent covalent inhibitors of papain-like protease from SARS-CoV-2

An efficient treatment against a COVID-19 disease, caused by the novel coronavirus SARS-CoV-2 (CoV2), remains a challenge. The papain-like protease (PL(pro)) from the human coronavirus is a protease that plays a critical role in virus replication. Moreover, CoV2 uses this enzyme to modulate the host...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weglarz-Tomczak, Ewelina, Tomczak, Jakub M., Talma, Michał, Burda-Grabowska, Małgorzata, Giurg, Mirosław, Brul, Stanley
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878891/ https://www.ncbi.nlm.nih.gov/pubmed/33574416 http://dx.doi.org/10.1038/s41598-021-83229-6

Ejemplares similares

Neutral metalloaminopeptidases APN and MetAP2 as newly discovered anticancer molecular targets of actinomycin D and its simple analogs
por: Węglarz-Tomczak, Ewelina, et al.
Publicado: (2018)

M2R: a Python add-on to cobrapy for modifying human genome-scale metabolic reconstruction using the gut microbiota models
por: Weglarz-Tomczak, Ewelina, et al.
Publicado: (2021)

GEM-Based Metabolic Profiling for Human Bone Osteosarcoma under Different Glucose and Glutamine Availability
por: Weglarz-Tomczak, Ewelina, et al.
Publicado: (2021)

Optimized Ebselen-Based Inhibitors of Bacterial Ureases with Nontypical Mode of Action
por: Macegoniuk, Katarzyna, et al.
Publicado: (2023)

Convergent Synthesis of Two Fluorescent Ebselen-Coumarin Heterodimers
por: Küppers, Jim, et al.
Publicado: (2016)

Ebselen derivatives inhibit SARS-CoV-2 replication by inhibition of its essential proteins: PL(pro) and M(pro) proteases, and nsp14 guanine N7-methyltransferase
por: Zmudzinski, Mikolaj, et al.
Publicado: (2023)

Potent and Selective Covalent Inhibition of the Papain-like Protease from SARS-CoV-2
por: Sanders, Brian, et al.
Publicado: (2022)

Potent and Selective Covalent Inhibition of the Papain-like Protease from SARS-CoV-2
por: Sanders, Brian, et al.
Publicado: (2022)

Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2
por: Sanders, Brian C., et al.
Publicado: (2023)

Inhibitory Potential of New Phenolic Hydrazide-Hydrazones with a Decoy Substrate Fragment towards Laccase from a Phytopathogenic Fungus: SAR and Molecular Docking Studies
por: Maniak, Halina, et al.
Publicado: (2021)

Structure-Based Design of Potent Peptidomimetic Inhibitors Covalently Targeting SARS-CoV-2 Papain-like Protease
por: Wang, Qian, et al.
Publicado: (2023)

Structure-Guided, Single-Point Modifications in the Phosphinic Dipeptide Structure Yield Highly Potent and Selective Inhibitors of Neutral Aminopeptidases
por: Vassiliou, Stamatia, et al.
Publicado: (2014)

Repurposing Known Drugs as Covalent and Non-covalent Inhibitors of the SARS-CoV-2 Papain-Like Protease
por: Delre, Pietro, et al.
Publicado: (2020)

New Chiral Ebselen Analogues with Antioxidant and Cytotoxic Potential
por: Pacuła, Agata J., et al.
Publicado: (2017)

Ebselen and Analogues: Pharmacological Properties and Synthetic Strategies for Their Preparation
por: Santi, Claudio, et al.
Publicado: (2021)

Parthenolide reveals an allosteric mode to inhibit the deISGylation activity of SARS-CoV‑2 papain-like protease: Parthenolide covalently inhibits papain-like protease
por: Zou, Zhihui, et al.
Publicado: (2022)

Synthesis and Structure-Activity Relationship Studies of Hydrazide-Hydrazones as Inhibitors of Laccase from Trametes versicolor
por: Maniak, Halina, et al.
Publicado: (2020)

Atomistic-Level Description of the Covalent Inhibition of SARS-CoV-2 Papain-like Protease
por: Hognon, Cécilia, et al.
Publicado: (2022)

Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
por: Chou, Chi-Yuan, et al.
Publicado: (2008)

In Vitro Anti-Prostate Cancer Activity of Two Ebselen Analogues
por: Kaczor-Keller, Katarzyna B., et al.
Publicado: (2020)

Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2
por: Shan, Hengyue, et al.
Publicado: (2021)

Natural biflavones are potent inhibitors against SARS-CoV-2 papain-like protease
por: Li, Lingyu, et al.
Publicado: (2022)

Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors
por: Osipiuk, Jerzy, et al.
Publicado: (2021)

The Se–S Bond Formation in the Covalent Inhibition Mechanism of SARS-CoV-2 Main Protease by Ebselen-like Inhibitors: A Computational Study
por: Parise, Angela, et al.
Publicado: (2021)

Binding of SARS-CoV Covalent Non-Covalent Inhibitors to the SARS-CoV-2 Papain-Like Protease and Ovarian Tumor Domain Deubiquitinases
por: Sivakumar, Dakshinamurthy, et al.
Publicado: (2021)

A covalent inhibitor targeting the papain-like protease from SARS-CoV-2 inhibits viral replication
por: Han, Hesong, et al.
Publicado: (2023)

THE REMOVAL OF CARTILAGE MATRIX, IN VIVO, BY PAPAIN : IDENTIFICATION OF CRYSTALLINE PAPAIN PROTEASE AS THE CAUSE OF THE PHENOMENON
por: McCluskey, Robert T., et al.
Publicado: (1958)

Antibacterial Activity of Ebselen
por: Maślanka, Marta, et al.
Publicado: (2023)

Role of Papain-Like Cysteine Proteases in Plant Development
por: Liu, Huijuan, et al.
Publicado: (2018)

Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease
por: Menéndez, Cintia A., et al.
Publicado: (2020)

Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives
por: Amporndanai, Kangsa, et al.
Publicado: (2021)

Establishing an Analogue Based In Silico Pipeline in the Pursuit of Novel Inhibitory Scaffolds against the SARS Coronavirus 2 Papain-Like Protease
por: Hajbabaie, Roxanna, et al.
Publicado: (2021)

Mercapto-pyrimidines are reversible covalent inhibitors of the papain-like protease (PLpro) and inhibit SARS-CoV-2 (SCoV-2) replication
por: Bajaj, Teena, et al.
Publicado: (2023)

X-ray Structural and Biological Evaluation of a Series of Potent and Highly Selective Inhibitors of Human Coronavirus Papain-like Proteases
por: Báez-Santos, Yahira M., et al.
Publicado: (2014)

Identification of potent food constituents as SARS-CoV-2 papain-like protease modulators through advanced pharmacoinformatics approaches
por: Bhowmick, Shovonlal, et al.
Publicado: (2022)

Simultaneous Integration of Gene Expression and Nutrient Availability for Studying the Metabolism of Hepatocellular Carcinoma Cell Lines
por: Weglarz-Tomczak, Ewelina, et al.
Publicado: (2021)

Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals
por: Sun, Le-Yun, et al.
Publicado: (2021)

Use of ebselen as a neuroprotective agent in rat spinal cord subjected to traumatic injury
por: Ślusarczyk, Wojciech, et al.
Publicado: (2019)

Electrochemical Biosensor for the Detection of SARS-CoV-2 Main Protease and Its Inhibitor Ebselen
por: Zhang, Qiongyu, et al.
Publicado: (2022)

Nidovirus papain-like proteases: Multifunctional enzymes with protease, deubiquitinating and deISGylating activities
por: Mielech, Anna M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tqrgjm3una3ulrqhp94skvu15j